Nichi-Iko Pharmaceutical Co., Ltd.   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Toyama Japan (1965)
Status: No NME R&D (1965)

Organization Overview

First Clinical Trial
2012
NCT01567358
First Marketed Drug
2016
nitroprusside (nipride)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree